Regen BioPharma issues 23.68M common shares for cash and debt conversion in Oct-Nov 2025

Regen BioPharma Inc

Oct 8, 2025: issued 6.8M shares for $68,000 cash.
Oct 27, 2025: issued 3.5M shares for $35,000 cash, and 4.5M shares to satisfy $30,204 debt principal plus $13,536 accrued interest.
Oct 28, 2025: issued 7.1M shares for $71,000 cash.
Nov 10, 2025: issued 1.78M shares for $17,800 cash under Tier 2 Reg A offering.
All shares sold directly by management with no underwriter or commission.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.